BEKSAÇ, M. Et Al. 2015. Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups. ACTA HAEMATOLOGICA , vol.133, no.4 , 372-380.

BEKSAÇ, M., Waage, A., Bringhen, S., Kristinsson, S. Y., Sucak, G. T., Gimsing, P., ... Lupparelli, G.(2015). Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups. ACTA HAEMATOLOGICA , vol.133, no.4, 372-380.

BEKSAÇ, MERAL Et Al. "Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups," ACTA HAEMATOLOGICA , vol.133, no.4, 372-380, 2015

BEKSAÇ, MERAL Et Al. "Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups." ACTA HAEMATOLOGICA , vol.133, no.4, pp.372-380, 2015

BEKSAÇ, M. Et Al. (2015) . "Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups." ACTA HAEMATOLOGICA , vol.133, no.4, pp.372-380.

@article{article, author={MERAL BEKSAÇ Et Al. }, title={Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups}, journal={ACTA HAEMATOLOGICA}, year=2015, pages={372-380} }